Hybrid cells created by fusion of antigen presenting and tumour cells have been shown to induce potent protective and curative anti-tumour immunity in rodent cancer models. The application of hybrid cell vaccines for human tumour therapy and the timely intervention in disease control are limited by the requirement to derive sufficient autologous cells to preserve homologous tumour antigen presentation. In this study, the efficiency of various methods of electrofusion in generating hybrid human cells have been investigated with a variety of human haemopoietic, breast and prostate cell lines. Cell fusion using an electrical pulse is enhanced by a variety of stimuli to align cells electrically or bring cells into contact. Centrifugation of cells after an exponential pulse from a Gene Pulser electroporation apparatus provided the highest yield of mixed cell hybrids by FACS analysis. An extensive fusogenic condition generated in human cells after an electrical pulse contradicts the presumption that prior cell contact is necessary for cell fusion. Alignment of cells in a concurrent direct current charge and osmotic expansion of cells in polyethylene glycol also generated high levels of cell fusion. Waxing of one electrode of the electroporation cuvette served to polarise the fusion chamber and increase cell fusion 5-fold. Optimisation of a direct current charge in combination with a fusogenic pulse in which fusion of a range of human cells approached or exceeded 30% of the total pulsed cells. The yield of hybrid prostate and breast cancer cells with dendritic cells was similar to the homologous cell fusion efficiencies indicating that dendritic cells were highly amenable to fusion with human tumour cells under similar electrical parameters. Elimination of unfused cells by density gradient and culture is possible to further increase the quantity of hybrid cells. The generation and purification of quantities of hybrid cells sufficient for human vaccination raises the possibility of rapid, autologous tumour antigen presenting vaccines for trial with common human tumours. ß
Introduction
Many tumours express distinct antigens which can be targeted in vaccine strategies aimed at promoting immunological defense mechanisms [1^3] . The demonstration that human malignancies carry speci¢c antigens, and the rejection of tumour cells in both animal models and humans, has set the stage for a new generation of cancer vaccines for promoting a curative immune response to tumours.
Tumour cells infrequently invoke a spontaneous immune response. Immunotherapy approaches have therefore attempted to increase the immunogenicity of transformed cells. However, the heterogeneity and unpredictability of immune function defects in human tumour precludes a single gene modi¢cation strategy for human cancer. Reduced or absent class I major histocompatability complex (MHC) expression is frequently observed in malignant cells of different origin [4, 5] , indicating that disrupted antigen presentation is a common means of immunological escape. Loss of the antigen transporting proteins TAP-1 and -2, required for stable MHC class I surface expression, correlates highly with MHC loss [68 ] . Interference with co-stimulatory molecule expression, required in combination with MHC antigen presentation, is indicated by the success of vaccination with B7 gene transfected tumour cells [9, 10] . An absence of co-stimulatory molecules might induce a negative signal resulting in T-cell anergy to tumour antigens. Additionally, defective expression of LMP genes, associated with antigen processing, have been detected in malignancy [11] . One study of cell lines established from prostate cancers showed that all lines examined were dysfunctional by quite di¡erent mechanisms [12] .
An attractive strategy that circumvents these di¤-culties is the use of a whole-cell vaccine composed of antigen presenting cells fused with the tumour cells [13^15] . Such cells would both express speci¢c tumour antigens and possess intact immunological molecules for antigen presentation and T-cell activation. Dendritic cells are bone marrow derived leukocytes whose capacity for stimulation of the immune system through T-cell-mediated responses are the most e¡ective of all known antigen-presenting cells (APCs) [16] . They possess an abundance of both classes of MHC molecules and present antigen for a prolonged period [17] accompanied by a range of costimulatory and adhesive accessory signals, including B7-1, B7-2, ICAM-1, ICAM-3, CD-40 [18] . The ability of highly motile dendritic cells to transport antigen to lymph nodes and activate e¡ector T-cells has led to their proposal as the ideal candidate for the induction of speci¢c anti-tumour immunity [19, 20] .
Dendritic cells transduced with tumour antigen RNA can induce speci¢c cytotoxic T-lymphocytes in vivo [21] . Dendritic cells pulsed with antigen [22] or expressing antigen from adenovirus or retrovirus viral vectors [23, 24] , confer potent protection against lethal tumour challenge in animal models. Hybrid cell vaccines produced by fusion of murine dendritic cells with colon adenocarcinoma cells [13] or B-lymphocytes or lymphocyte-derived cell lines fused with rat hepatocarcinoma cells [14] or myeloma cells [15] not only induced strong protection to tumour challenge but, most signi¢cantly in terms of human therapy, promoted the immunological rejection of established tumours in almost all animals.
The demonstration of protective murine responses to tumour fusion hybrids have utilised polyethylene glycol techniques developed for creating monoclonal antibody hybridomas [25] . Cell lines established from mouse antigen-presenting cells fused with syngeneic tumour cells were cultured to su¤cient quantities. The di¤culty in generating e¤cient cell fusion to prepare su¤cient quantities of hybrid, tumour-antigen-presenting cells without culture imposes a limitation in the furtherance of hybrid cell vaccines for autologous treatment of human cancers. Human vaccination will require a much more rapid and e¤cient procedure to achieve intervention at a therapeutic level before signi¢cant disease progression. We have explored the potential of a range of electrofusion protocols with the aim of preparing su¤cient hybrid cells to serve as an immediate autologous vaccine. Optimal conditions for simultaneous fusion of many APCs and cancer cells have been derived which should make hybrid cellular vaccines for cancer therapy feasible. This data should contribute to the rapid generation of autologous vaccines for treatment of cancer in human trials.
Materials and methods
Cell lines PC-3 and LNCaP (metastatic bone and lymph node derived human prostate adenocarcinoma cells, American Type Culture Collection (ATCC), Rockville, MD, USA; CRL-1435 and CRL-1740), 293 (adenovirus-transformed human embryonic kidney; ATCC 45504), and human breast adenocarcinoma cells MDA-MB-231 and MCF-7 (ATCC HTB-23 and HTB-22) were grown in Dulbecco's modi¢ed Eagle's medium supplemented with 10% foetal bo-vine serum (FBS), 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM L-glutamine (Sigma-Aldrich, Poole, Dorset). H9 and K562 (ATCC HTB-176 and CCL-243) cells were grown in RPMI 1640 medium supplemented with 10% FBS and the same additives. Dendritic cells were prepared by culture of CD34+ progenitor cells in a cytokine-supplemented medium. Haematopoietic progenitor cells were isolated by positive selection of CD34-expressing cells from cord blood using a MiniMACS CD34 Progenitor Cell Isolation Kit (Miltenyi Biotec). Cord blood, 50 ml collected in 10 ml Iscove's modi¢ed Eagle's medium containing 2 U/ml heparin (IMDM/heparin), was diluted 1:2 with phosphate-bu¡ered saline (PBS) containing 0.6% citrate dextrose formula A (ACD-A, Baxter) and 0.5% bovine serum albumin (BSA, Difco). Mononuclear cells were obtained by density gradient centrifugation over 0.5 vols. of Histopaque 1077 (Sigma-Aldrich) centrifuged for 30 min at 400Ug at 20³C. Cells banded at the interphase were collected and washed twice with 40 ml IMDM/heparin and viable cells counted after resuspension in PBS containing 3% acetic acid. Cells were then pelleted (200Ug for 10 min) and resuspended in cold IMDM/heparin at a concentration of 300 Wl per 10 8 mononuclear cells and treated with MiniMACS reagents as recommended by Miltenyi Biotec. Eluted CD34+ cells were then cultured at 5U10 5 cells/ml for 5 days in IMDM supplemented with 20% FCS, 100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM L-glutamine, 100 ng/ml recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF; RpD Systems), 20 ng/ml recombinant human interleukin 4 (IL-4; RpD Systems) and 20 ng/ml recombinant human Flt3/Flk2 ligand (RpD Systems), a procedure that resulted in s 95% MHC class II expressing cells as assessed by FACS analysis. Cells were harvested for electrofusion by after gentle pipetting, leaving tightly adherent cells.
Staining of cells
CellTracker Probes (Molecular Probes, Oregon, USA) 5-chloromethyl £uorescein diacetate (CMFDA) and 5-and 6-chloromethyl benzoyl amino tetramethylrhodamine (CMTMR) were supplied by Cambridge Bioscience and stored at 380³C as 10-mM stock solutions in dimethyl sulphoxide. These dyes, containing thiol-reactive chloromethyl groups, freely di¡use through cell membrane and interact with cytoplasmic glutathione transferases, forming impermeable £uorescent thioether adducts which prevents the leakage and transfer between cells [26, 27] . To determine the optimum staining conditions, cells at a density of 10 7 /ml were stained with a range of dye concentrations in growth medium for 30 min in the dark, washed twice in Hank's balanced salt solution (HBSS), replaced in the appropriate growth medium and examined by FACS analysis after various periods of incubation. Stained cells resuspended in fresh medium maintained £uorescent intensity and the same multiplication rate as unstained cells through at least four cell divisions. Moreover, cells stained with either CMFDA or CMTMR and incubated together for 24 h or more remained devisable into two populations with exclusive red or green £uorescence. The minimum concentrations (0.25 WM CMFDA and 4.5 WM CMTMR) of stains resulting in a log or greater di¡erence in £uorescent intensity between stained and unstained cells with all human cells were examined (data not shown). It was found that the £uorescent intensity was altered by an electrical charge given within 2 or 3 h of staining. Adherent cells were therefore replated in growth medium for 24 h after staining and retrypsinised prior to an experiment.
Electrofusion
For each fusion, equal numbers of cells were stained with CMFDA and with CMTMR. Cells were harvested the day following staining, washed twice in HBSS, viable numbers determined and cell density adjusted to 1.5U10 6 cells/ml in an isotonic solution of sucrose/NaCl passed through a 0.2-Wm ¢lter. Isotonic 0.3 M sucrose was used as the medium for cells during fusion unless otherwise stated. Molecular equivalents to formulate an isotonic solution with di¡ering proportions of sucrose and NaCl were established from Bergey's manual of chemical solutions. Electrofusion was performed with an equal proportion of mixed red and green £uorescent cells at a total of 1U10 6 cells per 0.75 ml in an electroplated cuvette (Bio-Rad). Inert wax (Difco Polywax 8829-19, melting temperature 57³C) was applied to one electrode of the cuvette by pipetting 150 Wl of liquid wax into a horizontally held, heated cuvette. Alternatively, a special chamber was made to test the e¡ect of centrifugation onto the basal electrode. A cone in a 4U1.5 cm cylinder of perspex [28] was capped with copper electrodes at base and apex, the upper electrode rotating on a thread to form a chamber of adjustable size for delivery of the pulse to cells pellet in line parallel to the direction of the pulse.
Cells were ¢rst aligned by means of direct or alternating electrical current supplied for 5 s prior to electrofusion. Electrofusion was driven by a Cober 605 pulse generator or a Bio-Rad Gene Pulser, delivering square or exponential pulses, respectively, connected to the power supply via an intervening Summation Box containing two diodes to prevent feedback, as depicted in Fig. 1 . The cuvette or chamber was left to stand for at least 5 min before cells were removed in a series of HBSS rinses. The total viable cell yield was established from the count of cells in an aliquot mixed with an equal volume of 0.4% trypan blue using a haemocytometer. Cells were than deposited by centrifugation at 3000 rpm for 5 min in a microfuge tube, ¢xed in 500Wl of PBS containing 1% paraformaldehyde and analysed by £ow cytometry (Becton Dickinson FACScan) with CellQuest software. Fused cell hybrids were largely discernible in forward vs side scatter plots as a pocket of larger and less refractile cells. The proportion of hybrids was enumerated in FL1 (green £uorescence) vs FL2 (red £uorescence) dot plots so that only hybrids of dual £uorescence were counted. Dead cells were excluded from the gate so as not to appear in the evaluation of % fusion and the number of dual £uorescent hybrids was calculated by multiplication with the proportion of live cells recovered, evaluated by trypan blue exclusion in a haemocytometer. Fluorescent microscopy examination of cells fused in different combinations showed an approximately equal tendency of cells to fuse with each other, with all green and all red hybrid cells approximating the numbers of red-green hybrid cells (data not shown).
Puri¢cation and ampli¢cation of hybrid cells
Density gradients composed of 6 ml of Polymorphprep (Nycomed, Birmingham) overlaid with 6 ml of 10 6 pulsed cell suspension in a 15-ml conical tube were centrifuged for 15 min at 500Ug. Hybrid cells, exhibiting dual £uorescence in FACS analysis appeared as a non-discrete, but distinct band below that of single cells. Increasing the concentration of dextran 500 to 10% w/v and centrifugation for a lesser time both served to increase the separation of the bands. Pooling the hybrid cell bands and repeated density gradient centrifugation reduced the yield of single stained cells. Hybrid cells, pelleted twice in PBS, were cultured in IMDM with 20% FBS in 25 cm 2 £asks. Approximately half the cells were examined by FACS every 5 days.
Results

Examination of electrical parameters
The e¡ect of applying an electrical charge of alternating or direct current (DC) on the integrity and permeability of cellular membranes was investigated with trypan blue dye. An alternating charge of 1 MHz applied to PC-3 cells in a cuvette at 1002 00 V per cm destabilised the membrane within 5 s, allowing temporary entry of trypan blue in greater than 50% of cells relative to the duration of the charge. Almost all stained cells charged with alternating current at these voltages were able to expel the dye within 30 min, indicating a temporary destabilisation of the membrane. Application of a direct current of greater than 50 V per cm for longer than 5 s did adversely a¡ect the survival of cells.
In trials, application of DC current of 12.5 to 100 V per cm to cells in a cuvette for 5 s prior to delivery of a pulse of 100 V/800 6/25 WFd by the Gene Pulser augmented the fusion rate several fold. Alternating current up 200 V/cm at 1 MHz applied to cells in the cuvette for 5 s prior to the electrical pulse did not signi¢cantly increase fusion of cells, despite an increase in trypan blue-permeability. Therefore a combination of DC current and a fusogenic pulse was used to drive cellular fusion as shown in Fig. 1 . A laboratory power supply, delivering a constant DC current, to compel cell contact prior to a fusogenic charge, is arranged in parallel to the Gene Pulser with an intervening summation box containing diodes to prevent feedback.
Examination of cell conductivity
Factors a¡ecting the duration of the electrical charge, measured by the Gene Pulser as the time to release 50% of the exponential pulse, were varied as detailed in Fig. 2 . The distance between plates of the cuvette, the conductivity of the solution determined by the concentration of salt in the isotonic cell medium and the application of an insulating wax applied to one electrode of the cuvette all modulated the conductivity. Waxing of the cuvette dramatically increased the pulse duration and the survival of the pulsed cells. Application of direct current to the cuvette for 5 s prior to the pulse brought a large increase in the proportion of hybrid cells without substantially a¡ecting cell survival. Addition of salt increased the percentage of fused cells proportionally, but also the severity of the condition, reducing the survival of pulsed cells. The overall production of hybrid cells was proportional to the pulse delivery time and became optimal between 15 and 20 ms.
Electrofusion of human cell lines
Electrofusion was performed over a range of electrical conditions using two prostate cancer cell lines and two breast cancer cell lines with variations in the DC current (VDC) and voltage (V), resistance (6) and capacitance (WFd) parameters of the Gene Pulser or voltage and pulse duration with the Pulse Generator. The e¡ect on fusion e¤ciencies is portrayed in a typical sample of conditions from reproducible experiments with LNCaP, PC-3, MCF-7 and MDA-MB-231 cells in Fig. 3 . The percentage of dual-£uo-rescent hybrid cells is enumerated in the upper right quadrant of each plot. FACS analysis of the pulsed cells counted only the mixed cell hybrids. Fluorescent microscopy demonstrated that the proportion of binucleate red hybrids and green hybrids was similar to the FACS enumeration of dual £uorescence hybrids or % fusion.
Each cell line behaved slightly di¡erently under the variations in charge. The proportion of hybrid MDA Table 1 . As might be expected, the Gene Pulser and DC supply voltages are additive, contributing to a fusion rate that can be optimised by inversely varying the two charges. At the higher Gene Pulser voltages, better fusion rates are achieved with the lower DC charge. The DC charge contributed to cell mortality and in combination with higher Gene Pulser voltages signi¢-cantly reduced yield of hybrid cells.
Alternative methods for cell alignment
A variety of conditions utilising polyethylene glycol and/or centrifugation to force cell contact or align cells in close proximity before or after application of a DC pulse were examined as detailed in Table 2 . Application of a DC current for 5 s prior to an exponential pulse was shown to moderately reduce cell survival, but improve cell fusion 5-fold, resulting in a 3.7-fold increase in hybrid cell yield. Relevant to the demonstration in the dielectrophoresis model of electrofusion [29] that maximal hybrid formation is not achieved till the third or fourth pulse, the e¡ect of multiple pulses were examined. After three pulses, the fusion rate was not improved in our conditions and the cell survival was reduced by a third. A square pulse, of constant charge for a speci¢c period, was compared to the exponential pulse delivered by the Gene Pulser in comparative media with the 4-mm cuvette. Increasing the amplitude of the square pulse between 125 and 500 V per cm (conditions 5^7), parameters that have been successful in dielectrophoresis model of cell fusion, did induce cell fusion, but to a lesser degree than the levels achieved with the exponential pulse. DC align- Capacitance and resistance were maintained at 25 WFd and 800 6. Live cells were counted in trypan blue and multiplied by % dual £uorescent hybrids to calculate total hybrid yield per condition. ND, not done. ment in combination with a square pulse doubled the proportion of hybrid cells in a waxed cuvette (condition 6 vs 4). No improvement of fusion was achieved by square pulses of higher voltages (condition 7). Increasing the pulse duration from 5 to 30 Ws (conditions 8^10) had little e¡ect on cell survival, but did not correlate with the rate of cell fusion. The e¡ect of alignment of cells relative to the £ow of current was observed with a specially constructed centrifugation chamber with a copper electrode base onto which the cells could be deposited. Centrifugation prior to the pulse in the cuvette (condition 11), depositing cells in a pellet perpendicular to the direction of the current, did not induce cell fusion much above the basal level of the pulse with suspended cells (condition 1). Pulsing of cells pelleted on the basal electrode of the chamber, parallel to the £ow of current, produced almost four times the proportion of fusion as the cells pelleted in the cuvette (condition 14 vs 11). Deposition of the cells immediately following the pulse (condition 12) was more successful that prior to the pulse and when combined with prior DC alignment induced the highest rate of hybrid cell yield of any condition observed (condition 15).
Polyethylene glycol (PEG) added to the isotonic 
Cross-matching of human cells
Cells of the same or di¡erent lineages were pulsed in a 1:1 ratio under the conditions of 60 VDC/200 V/ 25 WFd/800 6 per 4 mm cuvette (Table 3) . Most cells have a characteristic capacity to form hybrids under these conditions with the proportion of dual-£uores-cent hybrids varying less than 1 or 2% in repeated tests when healthy cells in mid-growth phase are used. The fusion e¤ciency of formation of mixed hybrids between cells of di¡erent lineage appears to be similar to the fusion rate obtained with homologous cells. The enumeration of hybrids by FACS evaluated hybrids of mixed cell type. The microscopic evaluation of fused suspension and adherent cell lines yielded approximately equal numbers of hybrid cells exhibiting red or green £uorescence and those showing red and green £uorescence (data not shown). The capacity for fusion of di¡erent suspension cell lines was found particularly variable, with the fusogenic cell line H9 performing better than most adherent lines. The survival rate of all suspension cell lines under these bu¡er conditions was approximately half or less of those of adherent cells, with 30% recovery or less of suspension cells after exposure to the pulse and harvesting.
Fusion with dendritic cells
MCF-7 and LNCaP cells mixed in 1:1 ratio with fresh dendritic cells were treated with DC current and pulsed with charges of similar parameters as previously used for these cell lines (Fig. 4) . Dendritic cells proved highly amenable to fusion with the cell lines investigated. Hybrids with dendritic cells were formed in similar proportion to homologous MCF-7 and LNCaP cell fusions (Fig. 3) . Generally, the optimal parameters of the pulse were very close to those found successful with the cell line to itself in each case. Dendritic cell hybrids yield with either MCF-7 or LNCaP cells did not improve with variations with in resistance (6) of the pulse, unlike the homologous cell fusions.
Puri¢cation and culture of hybrid cells
Unfused cells from experiments involving CD34+ cells pulsed with a variety of tumour cell lines were eliminated as separate bands in standard density gradients. Hybrid cells formed a di¡use lower band with 90^95% dual £uorescence by FACS analysis. Repeated density gradient centrifugation reduced, but did not eliminate, cells with only a single stain detectable by FACS. The proportion of the hybrid cells which attached to culture £asks was at least 50% of the proportion of total live cells. Plated cells initially grew slowly with a high proportion of the dual stained progeny cells not attaching to the culture plates. Further density gradient puri¢cation was nec- essary to prevent the overgrowth of the culture with single tumour cells. In each experiment, however, a stable population of dual stained cells was established in culture.
Discussion
We have investigated a variety of electrofusion strategies and established optimised electrofusion parameters for simple and reproducible creation of large numbers of dendritic cell/tumour cell hybrids for use as an anti-tumour vaccine. Hybrids in quantities that are being shown to be e¤cacious in human clinical trials [30^33] can be attained with minor ampli¢cation. Standard density gradient centrifugation enabled puri¢cation of hybrid cells and establishment of a stable population of hybrid cells with increasing plating e¤ciency and progressive doubling time. The possibility of culture of therapeutic quantities of hybrid cells rapidly could allow immunotherapeutic intervention with a vaccine of autologous tumour antigen-presenting cells before signi¢cant disease progression. In murine models, syngeneic tumour cells fused with antigen-presenting cells are protective of a variety of malignancies [13^15] . An initial helper T-cell and a speci¢c cytotoxic T-cell response were demonstrated in the protection of hybrid cell vaccinated mice to lymphoma [15] . E¤cient fusion and further culture ampli¢cation will provide su¤cient autologous hybrid cells with the requisite individual immunological speci¢city for human anti-tumour vaccination. The release of cells from solid tumours for fusion with dendritic cells could extend the application of hybrid cell vaccines to many malignancies.
The majority of previous studies of cell fusion have utilised antibodies to surface glycoproteins [34] or membrane dyes [28, 35] for staining of cells prior to electrofusion. Membrane fragmentation and amalgamation are common e¡ects of electric pulses to cells [36] and are well known to distort estimations of cell fusion [37, 38] . Li et al. [28] , for example, estimated a rate of fusion of 60^80% by membrane mixing but formation of hybrids was below 1%. The considerable disruption of cells inherent in the electrofusion process and the transfer of membrane fragments between cells makes surface staining a £awed method of assessing the proportion of hybrid cells. These experiments utilised £uorescent chloromethyl dyes which di¡use through the membranes of live cells, undergo a cytoplasmic glutathione S-transferase-mediated reaction and are retained in the cell [26] . A shift in cell refractivity caused by the pulse, observed when cells were pulsed immediately after staining, was lost at a rate that varied with di¡erent cell lines. In speci¢c tests, however, there was no transfer of dye between stained cells of any type. The low proportion of dual-£uo-rescent events detected by FACS after incubation without pulsing, equivalent to background positive level in control fusion panels, were observed by £uo-rescent microscopy as aggregates of individually stained cells and could be controlled by careful trituration. Cell recovery was elevated in experiments done without staining of cells and it is evident that while dye staining represents a reliable method for detection of mixed cell hybrids [26] it contributes considerably to cell mortality.
Electrofusion is commonly held to be a stepwise process, requiring a preliminary procedure to bring cells into alignment or close proximity prior to delivery of a DC pulse in which cell membranes are momentarily destabilised and fuse to form hybrid cells [26, 29] . Study of the behaviour of cells in electrical ¢elds has shown that transient membrane breakdown, allowing spontaneous and rapid resealing, occurs when short duration, high intensity electrical impulses of direct current are applied across the cell membrane [29, 39] . When impulses are greater than 2 kV/cm or exceed 100 Ws duration membrane breakdown is irreversible. A range of techniques have been employed as the preliminary step prior to pulse delivery. Both sonic and magnetic ¢elds can propel cells into contact prior to a pulse [40, 41] . Cells can be forced into close contact by centrifugation and fused together in a pellet [35, 38] or fused when in contact as a con£uent monolayer [42] . Likewise, a variety of chemical bridges have been used to improve the proportion of monoclonal antibody hybridomas [43, 44] and polymeric chemicals have been used to induce cell aggregation with electrofusion [45, 46] .
Membrane fusion can also be induced without any physical or chemical treatment of the cells. Teissie et al. [42] were able to form hybrid cells, evaluated at 5^10% with more than one nucleus, by simple appli-cation of ¢ve or more pulses of between 1 and 2 kV/ cm to cell monolayers on plastic culture plates. Similar fusion rates have been achieved between di¡erent adherent cells [40, 48] and indicates that physical contact is su¤cient to induce the fusion of cell membranes under conditions that cause the reversible breakdown of membrane integrity. On the other hand, the lower fusion rate achieved with most suspension cells may in part be due to the prior trypsinisation of adherent cell lines, since protease treatment reduces the intracellular spacing and the aqueous boundary between erythrocyte ghosts and improves the fusion rate [49, 50] .
The best studied electrofusion process, named dielectrophoresis, aligns cells closely by means of dipoles generated in an alternating current ¢eld with fusion triggered by a series of high intensity DC pulses [29] . It is argued that, as ¢eld strength is greatest along the axis of the applied current, aligning the cells with alternating current will serve to orient the sites of membrane breakdown and contribute to fusion [34] . It is possible that in conditions of high cell density the cells themselves may represent the electrical pathway of least resistance and the formation of pearl chains between the electrodes will be induced and contribute to fusion. We could not reproduce pearl chain formation in a cuvette and observed instead the alignment of cells midway between electrodes under alternating current, perpendicular to the electrical axis. Generally, this method has been applied to the production of antibody hybridomas and the addition to the fusion rate has not been critically evaluated. The propensity of dielectrophoresis to fuse cells of similar size, selecting activated lymphocytes for fusion to the larger murine myeloma cells [51] , may partially account for the higher output of productive hybridomas. Preliminary alignment of cells in alternating current in the cuvette did not signi¢cantly augment the fusion rate. By contrast, it was found that the application of a direct current to the cells prior to pulse delivery forced the cells in close juxtaposition on the positive electrode of the cuvette and contributed to cell fusion. A signi¢cant fusion rate was only observed in conjunction with a wax covering to one electrode. This insulation layer, by limiting current £ow to a critical point, could reduce detrimental Joule heating and allow the build-up of an electrostatic ¢eld, polarising the electrodes and thereby inducing the critical aggregation of cells on the anode.
The most critical parameters in electrofusion affecting hybrid cell yield were the strength and duration of the electrical pulse. In agreement with others [39, 52] , we observed these parameters to be inversely related. A pulse of shorter time can be compensated by increasing the conductivity of the medium or chamber or increasing the pulse ¢eld strength to achieve an equivalent level of fusion. For a particular electrical charge, however, a set pulse duration of between 15 and 20 ms was optimal for yield of hybrid cells. The DC current and the pulse charge were also roughly reciprocal in overall yield of hybrid cells, the improvement in the fusion rate with higher values of DC current or pulse charge being counterbalanced by accruing cell mortality. The proportion of fused cells of di¡erent cell lines varied with each modulation of the DC current and charge, capacitance and resistance parameters of the Gene Pulser. The optimal set of electrical parameters yielding the greatest number of hybrid cells could be reproducibly de¢ned, but varied considerably for each cell line studied. The highest level of hybrid formation was characteristic of each cell line with some cells in this study, such as H9 cells, being intrinsically more fusogenic than others. De¢nition of best electrofusion parameters for a new cell line, therefore, needs to be performed across a wide range of electrical conditions in the ¢rst instance. The indications that low and high variations in resistance of the cell adversely a¡ect fusion with dendritic cells could simplify prospective investigations of the optimised electrical parameters for patient tumour cell and dendritic cell fusions to amplitude of the charge (V) of the pulse and DC charge.
The combination of DC alignment and DC pulse was the preferred means of hybrid formation although alternative methods using centrifugation or causing cell aggregation by dilution of a PEGcontaining medium gave equivalent or greater yield of hybrids. The relatively simple means of optimising the two electrical parameters to suit each new cell line were advantageous. The commonly used chemical fusogen PEG, causing hygroscopic aggregation and shrinkage of cells, mimics other physical methods to bring cells into contact. The fusion rate of cells pulsed in PEG-containing medium, in contrast with previous results with CHO cells [53] , increased with the concentration of PEG. Fusion in PEG also improved with concurrent alignment by DC charge, but cell survival was overwhelmingly a¡ected by combining PEG incubation with either DC alignment or centrifugation. It is the removal of PEG after incubation of B-cells and myeloma cells that is thought to initiate fusion through cell swelling [54, 55] . Thus, dilution of the PEG concentration in the cuvette immediately after the pulse brought about a large increase in fusion.
The higher fusion rate achieved by centrifugation after the pulse rather than before, as seen with PC-3 cells, may contradict the premise that cells need to be in contact or close proximity at the time the pulse is delivered [26, 29] . The resealing time for membrane bilayers disrupted by electrical pulses is very rapid [56] , but there is a component of electropermeabilised cells that persists for extended periods. Tiessie and Rols [57] observed that a high intensity pulse of 800^1600 V/cm created a long-lasting condition of permeability which gradually disappeared over 40 min. A higher fusion rate obtained by centrifugation subsequent to the pulse has been observed before [57, 58] and indicates that forcing cell contact before applying the pulse is not the only way to generate electrofusion.
Hybrid cells puri¢ed from fused human tumour and CD34+ cells gradually assumed an e¤cient growth pattern in culture. Attempts to establish cultures of hybrid cells with dendritic cells matured with cytokines from peripheral blood monocytes [59, 60] were unsuccessful and it could be that the added replicative potential of early progenitor cells is required to form stable hybrid populations. Syngeneic hybrid cells have been shown to be immunologically protective in murine malignancies. The high levels of electrofusion demonstrated with a variety of strategies in this report and the subsequent culture of fused cells overcomes many of the technical obstacles to generating su¤cient autologous hybrid cells with individual speci¢city for human anti-cancer vaccination.
